Management of bile duct tumors

Author： Seehofer Daniel   Kamphues Carsten   Neuhaus Peter  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.16, 2008-11, pp. : 2843-2856

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage

By Merli Manuela  

Clinical Drug Investigation, Vol. 30, Iss. 3, 2010-03 ,pp. : 205-209

Adis International

Access to resources Recommend Favorite

The nonadrenergic noncholinergic relaxation of anococcygeus muscles of bile duct-ligated rats

By Dehpour A.R.   Seyyedi A.   Rastegar H.   Namiranian K.   Moezi L.   Sadeghipour H.   Dehghani M.   Jorjani M.   Roushanzamir F.   Ahmadiani A.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 31-36

Elsevier

Access to resources Recommend Favorite

Tenoxicam: Cholestasis and first report of vanishing bile duct syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1016, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Zonisamide: First report of vanishing bile duct syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1134, 2007-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Effect of Cisapride on the Isolated Guinea Pig Gall Bladder and Common Bile Duct

By Koutsoviti-Papadopoulou M.   Kounenis G.   Batzias G.   Elezoglou V.  

General Pharmacology, Vol. 29, Iss. 5, 1997-11 ,pp. : 863-867

Elsevier

Access to resources Recommend Favorite